Search research articles
Contact Us
Filters
Showing results (11-20 of 335) with videos related to
Page
of 34
Sort By:
Nature
|
April 18, 2003
Medicine: Collateral damage repaired
Lawrence Steinman
Journal of Neurochemistry
|
June 24, 2020
A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on page 486
Lawrence Steinman
The Journal of Experimental Medicine
|
May 7, 2003
Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year
Lawrence Steinman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 21, 2011
Inverse vaccination to silence immunity to myelin in multiple sclerosis
Lawrence Steinman
Nature Immunology
|
May 28, 2004
Elaborate interactions between the immune and nervous systems
Lawrence Steinman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 28, 2015
Parsing Physiological Functions of Erythropoietin One Domain at a Time
Lawrence Steinman
Journal of the Neurological Sciences
|
September 5, 2008
New targets for treatment of multiple sclerosis
Lawrence Steinman
European Journal of Immunology
|
October 17, 2014
Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease
Lawrence Steinman
The Journal of Cell Biology
|
October 31, 2012
The discovery of natalizumab, a potent therapeutic for multiple sclerosis
Lawrence Steinman
The Journal of Clinical Investigation
|
April 2, 2015
No quiet surrender: molecular guardians in multiple sclerosis brain
Lawrence Steinman
Page
of 34
Search research articles
Search
Showing results (11-20 of 335) with videos related to
Sort By:
Page
of 34
Nature
|
April 18, 2003
Medicine: Collateral damage repaired
Lawrence Steinman
Journal of Neurochemistry
|
June 24, 2020
A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on page 486
Lawrence Steinman
The Journal of Experimental Medicine
|
May 7, 2003
Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year
Lawrence Steinman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 21, 2011
Inverse vaccination to silence immunity to myelin in multiple sclerosis
Lawrence Steinman
Nature Immunology
|
May 28, 2004
Elaborate interactions between the immune and nervous systems
Lawrence Steinman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 28, 2015
Parsing Physiological Functions of Erythropoietin One Domain at a Time
Lawrence Steinman
Journal of the Neurological Sciences
|
September 5, 2008
New targets for treatment of multiple sclerosis
Lawrence Steinman
European Journal of Immunology
|
October 17, 2014
Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease
Lawrence Steinman
The Journal of Cell Biology
|
October 31, 2012
The discovery of natalizumab, a potent therapeutic for multiple sclerosis
Lawrence Steinman
The Journal of Clinical Investigation
|
April 2, 2015
No quiet surrender: molecular guardians in multiple sclerosis brain
Lawrence Steinman
Page
of 34